F-group (family)
223.1.1.29 PAS_11
Ligands and drugs
280
Member domains
58
with ligand contacts (≤ 4 Å)
20.7% of members
47
with DrugDomain annotations
16.8% of members
22
with a DrugBank compound
7.9% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 223.1.1.29 belongs to X-group 223 Profilin-like, which binds 8.8 ligand superclasses per 20 proteins, broader than 74% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB04447 | DTT | 1,4-Dithiothreitol | 8 |
| DB03556 | PE5 | 2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400 | 2 |
| DB15463 | 72Q | Belzutifan | 2 |
| DB16055 | 79A | PT-2385 | 2 |
| DB01123 | PRL | Proflavine | 1 |
| DB12255 | — | Vadadustat | 1 |
| DB16495 | 5YM | Oleic monoethanolamide | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| DTT | 2,3-DIHYDROXY-1,4-DITHIOBUTANE | 11 |
| 0X3 | N-(3-chloro-5-fluorophenyl)-4-nitro-2,1,3-benzoxadiazol-5-amine | 2 |
| 43L | (5S,7R)-5,7-bis(3-bromophenyl)-4,5,6,7-tetrahydrotetrazolo[1,5-a]pyrimidine | 2 |
| 79A | 3-{[(1S)-2,2-difluoro-1-hydroxy-7-(methylsulfonyl)-2,3-dihydro-1H-inden-4-yl]oxy}-5-fluorobenzonitrile | 2 |
| MVC | MONOVACCENIN | 2 |
| P6G | HEXAETHYLENE GLYCOL | 2 |
| PE5 | 3,6,9,12,15,18,21,24-OCTAOXAHEXACOSAN-1-OL | 2 |
| YL8 | 5-[3,5-bis(trifluoromethyl)phenyl]-2H-tetrazole | 2 |
| 018 | 2-nitro-N-(thiophen-3-ylmethyl)-4-(trifluoromethyl)aniline | 1 |
| 020 | N-(furan-2-ylmethyl)-2-nitro-4-(trifluoromethyl)aniline | 1 |
| 0XB | N-(3-fluorophenyl)-4-nitro-2,1,3-benzoxadiazol-5-amine | 1 |
| 2XY | N-[2-nitro-4-(trifluoromethyl)phenyl]morpholin-4-amine | 1 |
| 5YM | (Z)-N-(2-hydroxyethyl)octadec-9-enamide | 1 |
| 72Q | 3-{[(1S,2S,3R)-2,3-difluoro-1-hydroxy-7-(methylsulfonyl)-2,3-dihydro-1H-inden-4-yl]oxy}-5-fluorobenzonitrile | 1 |
| 86D | 3-({(1S)-7-[(difluoromethyl)sulfonyl]-2,2-difluoro-1-hydroxy-2,3-dihydro-1H-inden-4-yl}oxy)-5-fluorobenzonitrile | 1 |
| A1EJ8 | 4-fluoranyl-1,1-bis(oxidanylidene)-~{N}-(2-pyrrolidin-1-ylphenyl)-1,2-benzothiazol-3-amine | 1 |
| A1EJ9 | 4-chloranyl-1,1-bis(oxidanylidene)-~{N}-(2-pyrrolidin-1-ylphenyl)-1,2-benzothiazol-3-amine | 1 |
| A1EKA | 6-chloranyl-1,1-bis(oxidanylidene)-~{N}-(2-pyrrolidin-1-ylphenyl)-1,2-benzothiazol-3-amine | 1 |
| A1EKB | 4-fluoranyl-~{N}-(3-fluoranyl-2-pyrrolidin-1-yl-phenyl)-1,1-bis(oxidanylidene)-1,2-benzothiazol-3-amine | 1 |
| A1H3P | (2~{S})-3-[(4-ethyl-1-benzofuran-7-yl)oxy]-2-fluoranyl-propan-1-ol | 1 |